Anderson Raymond: insider trades.
Anderson Raymond reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($703K), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Anderson Raymond
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Monopar Therapeutics (MNPR) | Director | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-25 | Monopar Therapeutics | S | 646 | $111.07 | 7,175 | Form 4/A |
| 2026-08-25 | Monopar Therapeutics | M | 1,402 | $30 | 6,775 | Form 4/A |
| 2026-08-25 | Monopar Therapeutics | M | 1,740 | $30 | 8,515 | Form 4/A |
| 2026-08-25 | Monopar Therapeutics | S | 694 | $110.04 | 7,821 | Form 4/A |
| 2026-08-25 | Monopar Therapeutics | S | 1,802 | $113.05 | 5,373 | Form 4/A |
| 2026-08-25 | Monopar Therapeutics | S | 694 | $110.04 | 26,169 | Form 4 |
| 2026-08-25 | Monopar Therapeutics | S | 646 | $110.07 | 25,523 | Form 4 |
| 2026-08-25 | Monopar Therapeutics | S | 1,802 | $113.05 | 23,751 | Form 4 |
Questions
What stock did Anderson Raymond buy or sell?
Anderson Raymond reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($703K), across 1 company.
Is Anderson Raymond the same person as other filers with this name?
This page covers SEC CIK 1362489 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/anderson-raymond-1362489.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.